Newsroom

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 4/23/2026 Issue ¦ Toyota Finance Australia Limited - Series 336 USD 400,000,000 FRN due April 2029     ISIN Number ¦ XS3273847916 ISIN Reference ¦ 327384791 Issue Nomin USD ¦ 400000000 Period ¦ 1/30/2026 to 4/30/2026   Payment Date 4/30/2026 Number of Days ¦ 90 Rate ¦ 4.2687   Denomination USD ¦ 1000   ¦ 400000000   ¦       Amount Payable per Denomination ¦ 10.67   ¦ 4268000   ¦       Bank of New Yo...

PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), société pharmaceutique spécialisée dans le développement et la commercialisation de traitements innovants pour les personnes souffrant de maladies rénales rares, annonce que son Document d’Enregistrement Universel 2025 a été déposé auprès de l’Autorité des Marchés Financiers. Le Document d’Enregistrement Universel inclut notamment le rapport annuel, le rapport de gestion de la société, le rapport du...

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain and peripheral diseases involving the CB1 receptor, today announces the publication of its 2025 Universal Registration Document (URD) as filed with the French Financial Markets Authority (Autorité des Marchés Financiers (AMF)) on April 23, 2026, under number D.26-0284. The Universal Registration D...

TORONTO--(BUSINESS WIRE)--Sunnybrook Health Sciences Centre is proud to announce a $41M philanthropic investment in Sunnybrook Clinical Trials. The investment expands dedicated infrastructure, capacity and expertise across Sunnybrook to optimize how clinical trials are designed and delivered. This will significantly accelerate the journey from discovery to patient impact, delivering promising therapies to more patients faster, and positioning Canada as a global leader in high-impact clinical tr...

FREMONT, Calif.--(BUSINESS WIRE)--AXT, Inc. (NasdaqGS: AXTI) (“AXT” or the “Company”), a leading manufacturer of compound semiconductor wafer substrates, announced today that, in connection with its recently completed underwritten public offering of 8,560,311 shares of common stock, the underwriters have exercised their over-allotment option to purchase an additional 1,284,046 shares of common stock at a price to the public of $64.25 for additional gross proceeds of approximately $82.5 million,...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of LKQ Corporation (“LKQ” or the “Company”) (NASDAQ: LKQ) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON LKQ CORPORATION (LKQ), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On April 23, 20...

MINNEAPOLIS--(BUSINESS WIRE)--Kradle, a premium pet wellness brand known for its innovative and easy-to-use natural calming solutions for dogs and cats, today announced its national launch with Petco. The partnership brings Kradle’s dog calming products to most Petco stores nationwide this month, with an expanded portfolio of products available online at petco.com now. With rising awareness of canine anxiety and behavioral health, calming has become a critical entry point into overall pet welln...

PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, announces today that its 2025 Universal Registration Document has been filed with the French Autorité des Marchés Financiers (AMF). The Universal Registration Document includes the annual report, the management report, the Board of Directors' report on cor...

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements des maladies cérébrales et périphériques impliquant le récepteur CB1, annonce la mise à disposition de son Document d’Enregistrement Universel 2025 déposé auprès de l’AMF le 23 avril 2026 sous le numéro D.26-0284. Le Document d'Enregistrement Universel 2025 inclut notamment : le...

LONDON--(BUSINESS WIRE)--Regulatory News: MotorK PLC (AMS: MTRK) ("MotorK", the "Group" or the "Company"), a leading SaaS provider to the automotive retail industry in the EMEA region, today announced its financial results for the first quarter of 2026 (“Q1 26”), reporting improvement in profitability. Q1 26 Financial Highlights: Committed Annual Recurring Revenue (CARR1): €33.5M, a 9% decrease compared with €36.8M in Q1 25, reflecting a focus on higher-quality, longer-duration contracts with s...